|
|
Line 19: |
Line 19: |
| src: url(https://static.igem.org/mediawiki/2020/5/54/T--UCopenhagen--Avenir_light.ttf); | | src: url(https://static.igem.org/mediawiki/2020/5/54/T--UCopenhagen--Avenir_light.ttf); |
| } | | } |
| + | |
| + | h10 { |
| + | font-family: Montserrat; font-size: 1em; line-height: 1.25; |
| + | } |
| | | |
| </style> | | </style> |
Line 52: |
Line 56: |
| since the first_text class is used above, this section will appear by default --> | | since the first_text class is used above, this section will appear by default --> |
| <div class="info"> | | <div class="info"> |
− | <div class="title">CIDosis - A Monitoring Tool for Chronic Inflammatory Diseases</div> | + | <div class="title"><h10>CIDosis - A Monitoring Tool for Chronic Inflammatory Diseases</h10></div> |
| <div class="text"> | | <div class="text"> |
| | | |
Line 65: |
Line 69: |
| <br><br> | | <br><br> |
| <img src="https://static.igem.org/mediawiki/2020/2/26/T--UCopenhagen--Poster_Description.png"> | | <img src="https://static.igem.org/mediawiki/2020/2/26/T--UCopenhagen--Poster_Description.png"> |
− | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;"><b>Fig. 1. Visual representation of the usage of the CIDosis patch and the engineering and scientific approach. </b>1: The patch collecting sweat from the skin. 2: The layers in the patch. 3: The scientific receptor engineering. 4: The patch after it has changed color. 5: The image-analyzing app.</figcaption> | + | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25; text-align: center; margin-top: 1%;"><b>Fig. 1. Visual representation of the usage of the CIDosis patch and the engineering and scientific approach. </b>1: The patch collecting sweat from the skin. 2: The layers in the patch. 3: The scientific receptor engineering. 4: The patch after it has changed color. 5: The image-analyzing app.</figcaption> |
| | | |
| | | |
Line 118: |
Line 122: |
| <br> | | <br> |
| <img src="https://static.igem.org/mediawiki/2020/0/03/T--UCopenhagen--Poster_ubiquitin.png"> | | <img src="https://static.igem.org/mediawiki/2020/0/03/T--UCopenhagen--Poster_ubiquitin.png"> |
− | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;"><b>Fig. 2. Minimal biosensor design. </b> | + | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;text-align: center; margin-top: 1%;"><b>Fig. 2. Minimal biosensor design. </b> |
| Complementation of the C- and N-terminal halves of Ubiquitin results in their recognition by deubiquitinating enzymes, leading to cleavage and release of the bound LexA-VP16 transcription factor.</figcaption> | | Complementation of the C- and N-terminal halves of Ubiquitin results in their recognition by deubiquitinating enzymes, leading to cleavage and release of the bound LexA-VP16 transcription factor.</figcaption> |
| | | |
Line 141: |
Line 145: |
| <br> | | <br> |
| <img src="https://static.igem.org/mediawiki/2020/3/3c/T--UCopenhagen--Poster_int.png"> | | <img src="https://static.igem.org/mediawiki/2020/3/3c/T--UCopenhagen--Poster_int.png"> |
− | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;"><b>Fig. 3. Intermediate biosensor design. </b> | + | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25; text-align: center;margin-top: 1%;"><b>Fig. 3. Intermediate biosensor design. </b> |
| Split TEV protease complementation leading to cleavage of the linker tethering the transcription factor LexA-VP16 to the membrane.</figcaption> | | Split TEV protease complementation leading to cleavage of the linker tethering the transcription factor LexA-VP16 to the membrane.</figcaption> |
| | | |
Line 168: |
Line 172: |
| | | |
| <img src="https://static.igem.org/mediawiki/2020/8/88/T--UCopenhagen--Poster_G_alpha_Design.png"> | | <img src="https://static.igem.org/mediawiki/2020/8/88/T--UCopenhagen--Poster_G_alpha_Design.png"> |
− | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;"><b>Fig. 4. Advanced biosensor design.</b> | + | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;text-align: center;margin-top: 1%;"><b>Fig. 4. Advanced biosensor design.</b> |
| Split TEV protease complementation leading to cleavage of a TEV protease cut site in GPA1, thereby initiating gene expression through the yeast pheromone pathway.</figcaption> | | Split TEV protease complementation leading to cleavage of a TEV protease cut site in GPA1, thereby initiating gene expression through the yeast pheromone pathway.</figcaption> |
| | | |
Line 195: |
Line 199: |
| <br><br> | | <br><br> |
| <img src="https://static.igem.org/mediawiki/2020/4/48/T--UCopenhagen--Poster_dyn.png"> | | <img src="https://static.igem.org/mediawiki/2020/4/48/T--UCopenhagen--Poster_dyn.png"> |
− | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;"><b>Fig. 5. Comparison of the dynamic ranges of our designs. </b> Plotting reporter signal strength against interleukin concentration in uM reveals a significant difference in sensitivity between the three designs. | + | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;text-align: center;margin-top: 1%;"><b>Fig. 5. Comparison of the dynamic ranges of our designs. </b> Plotting reporter signal strength against interleukin concentration in uM reveals a significant difference in sensitivity between the three designs. |
| </figcaption> | | </figcaption> |
| | | |
Line 204: |
Line 208: |
| <br><br> | | <br><br> |
| <img src="https://static.igem.org/mediawiki/2020/a/a4/T--UCopenhagen--Poster_rep.png"> | | <img src="https://static.igem.org/mediawiki/2020/a/a4/T--UCopenhagen--Poster_rep.png"> |
− | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;"><b>Fig. 6. The effect of reporter toxicity on the reporter concentration. </b>The amount of noise applied to all variables increases with reporter concentration, which leads to highly variable reporter concentrations (illustrative) | + | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;text-align: center;margin-top: 1%;"><b>Fig. 6. The effect of reporter toxicity on the reporter concentration. </b>The amount of noise applied to all variables increases with reporter concentration, which leads to highly variable reporter concentrations (illustrative) |
| </figcaption> | | </figcaption> |
| | | |
Line 214: |
Line 218: |
| <br><br> | | <br><br> |
| <img src="https://static.igem.org/mediawiki/2020/8/87/T--UCopenhagen--Poster_m124.png"> | | <img src="https://static.igem.org/mediawiki/2020/8/87/T--UCopenhagen--Poster_m124.png"> |
− | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;"><b>Fig. 7. Change in Gibbs free energy of fragments produced after cleavage of GPA1 mutant m124. </b>The positions of each fragment in the original protein is denoted on the x-axis. Negative values suggest increased affinity to the beta subunit of the yeast G protein. | + | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;text-align: center;margin-top: 1%;"><b>Fig. 7. Change in Gibbs free energy of fragments produced after cleavage of GPA1 mutant m124. </b>The positions of each fragment in the original protein is denoted on the x-axis. Negative values suggest increased affinity to the beta subunit of the yeast G protein. |
| </figcaption> | | </figcaption> |
| | | |
Line 264: |
Line 268: |
| <br><br> | | <br><br> |
| <img src="https://static.igem.org/mediawiki/2020/c/c8/T--UCopenhagen--Poster_workflow.png"> | | <img src="https://static.igem.org/mediawiki/2020/c/c8/T--UCopenhagen--Poster_workflow.png"> |
− | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;"><b>Fig. 8. General scientific workflow.</b></figcaption> | + | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;text-align: center;margin-top: 1%;"><b>Fig. 8. General scientific workflow.</b></figcaption> |
| <br> | | <br> |
| <br> | | <br> |
Line 277: |
Line 281: |
| <br><br> | | <br><br> |
| <img src="https://static.igem.org/mediawiki/2020/c/c0/T--UCopenhagen--Poster_5ass.png"> | | <img src="https://static.igem.org/mediawiki/2020/c/c0/T--UCopenhagen--Poster_5ass.png"> |
− | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;"><b>Fig. 9. The 5-assembler system. </b>The biosensor is assembled by co-transforming five linearized module plasmids that contain a promoter and a coding sequence, with both being flanked by homologous recombination regions.</figcaption> | + | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;text-align: center;margin-top: 1%;"><b>Fig. 9. The 5-assembler system. </b>The biosensor is assembled by co-transforming five linearized module plasmids that contain a promoter and a coding sequence, with both being flanked by homologous recombination regions.</figcaption> |
| | | |
| | | |
Line 314: |
Line 318: |
| <br> | | <br> |
| <img src="https://static.igem.org/mediawiki/2020/1/1c/T--UCopenhagen--Poster_yeast_col.png"> | | <img src="https://static.igem.org/mediawiki/2020/1/1c/T--UCopenhagen--Poster_yeast_col.png"> |
− | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;"><b>Fig. 10. Yeast colony PCR. </b>A band at 1500 bp meant no insertion into the locus, while a band at 1000 bp implied successful insertion of the five vectors. Arrow a and b denote positive and negative bands respectively.</figcaption> | + | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;text-align: center;margin-top: 1%;"><b>Fig. 10. Yeast colony PCR. </b>A band at 1500 bp meant no insertion into the locus, while a band at 1000 bp implied successful insertion of the five vectors. Arrow a and b denote positive and negative bands respectively.</figcaption> |
| | | |
| <br><br> | | <br><br> |
Line 320: |
Line 324: |
| Through our extensive subcellular localization assays for all the three designs, we found that localization issues of the interleukin receptor proteins and accessory proteins were prominent for several of the proteins. <br><br> | | Through our extensive subcellular localization assays for all the three designs, we found that localization issues of the interleukin receptor proteins and accessory proteins were prominent for several of the proteins. <br><br> |
| <img src="https://static.igem.org/mediawiki/2020/e/ec/T--UCopenhagen--Poster_cells.png"> | | <img src="https://static.igem.org/mediawiki/2020/e/ec/T--UCopenhagen--Poster_cells.png"> |
− | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;"><b>Fig. 11. Example of subcellular localization assay result. </b>sIL-10R1-Cub is shown to primarily localize to the plasma membrane, in the endoplasmic reticulum, and in small inclusion bodies near the membrane.</figcaption> | + | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;text-align: center;margin-top: 1%;"><b>Fig. 11. Example of subcellular localization assay result. </b>sIL-10R1-Cub is shown to primarily localize to the plasma membrane, in the endoplasmic reticulum, and in small inclusion bodies near the membrane.</figcaption> |
| | | |
| | | |
Line 328: |
Line 332: |
| Induction of the TEV protease was shown to effectively cleave our membrane-bound transcription factor containing a TEV recognition site in a flexible linker, thereby inducing the expression of our reporter gene of interest.<br><br> | | Induction of the TEV protease was shown to effectively cleave our membrane-bound transcription factor containing a TEV recognition site in a flexible linker, thereby inducing the expression of our reporter gene of interest.<br><br> |
| <img src="https://static.igem.org/mediawiki/2020/c/c3/T--UCopenhagen--Poster_TMD_TF.png"> | | <img src="https://static.igem.org/mediawiki/2020/c/c3/T--UCopenhagen--Poster_TMD_TF.png"> |
− | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;"><b>Fig. 12. Luminescence assay based on cleavage of a membrane-bound transcription factor. </b>Cells were expressed without (glucose media) and with (galactose+raffinose media) induction of the TEV protease. A 1300-fold increase in luminescence was seen upon induction of the TEV protease. The data shown is the average of three biological replicates.</figcaption> | + | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;text-align: center;margin-top: 1%;"><b>Fig. 12. Luminescence assay based on cleavage of a membrane-bound transcription factor. </b>Cells were expressed without (glucose media) and with (galactose+raffinose media) induction of the TEV protease. A 1300-fold increase in luminescence was seen upon induction of the TEV protease. The data shown is the average of three biological replicates.</figcaption> |
| | | |
| | | |
Line 337: |
Line 341: |
| <br><br> | | <br><br> |
| <img src="https://static.igem.org/mediawiki/2020/9/93/T--UCopenhagen--Poster_Ga_assays.png"> | | <img src="https://static.igem.org/mediawiki/2020/9/93/T--UCopenhagen--Poster_Ga_assays.png"> |
− | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;"><b>Fig. 13. Characterization of modified GPA1 proteins in adenosine biosensor. </b>The biosensors were grown in either glucose media or galactose + raffinose media which repressed or activated expression of a TEV protease. The biosensors were further grown with a dilution series of adenosine.</figcaption> | + | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;text-align: center;margin-top: 1%;"><b>Fig. 13. Characterization of modified GPA1 proteins in adenosine biosensor. </b>The biosensors were grown in either glucose media or galactose + raffinose media which repressed or activated expression of a TEV protease. The biosensors were further grown with a dilution series of adenosine.</figcaption> |
| | | |
| | | |
Line 345: |
Line 349: |
| No correlation between interleukin concentration and luminescence was observed for the minimal IL-6 and IL-10 biosensor strains at any incubation time. | | No correlation between interleukin concentration and luminescence was observed for the minimal IL-6 and IL-10 biosensor strains at any incubation time. |
| <br><br><img src="https://static.igem.org/mediawiki/2020/1/17/T--UCopenhagen--Poster_IL6.png"> | | <br><br><img src="https://static.igem.org/mediawiki/2020/1/17/T--UCopenhagen--Poster_IL6.png"> |
− | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;"><b>Fig. 14. Luciferase assay of the minimal interleukin-6 biosensor. </b>The amount of luminescence observed after incubation with a dilution series of interleukin-6 for 1, 3, 14 and 22 hours.</figcaption> | + | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;text-align: center;margin-top: 1%;"><b>Fig. 14. Luciferase assay of the minimal interleukin-6 biosensor. </b>The amount of luminescence observed after incubation with a dilution series of interleukin-6 for 1, 3, 14 and 22 hours.</figcaption> |
| | | |
| | | |
Line 386: |
Line 390: |
| | | |
| <img src="https://static.igem.org/mediawiki/2020/c/cf/T--UCopenhagen--Poster_survey.png"> | | <img src="https://static.igem.org/mediawiki/2020/c/cf/T--UCopenhagen--Poster_survey.png"> |
− | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;"><b>Fig. 15. Snippet of survey results. </b>Survey results showing the frequency of CID testing and desired frequency of wearing the CIDosis patch.</figcaption> | + | <figcaption style="font-family: Avenir, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.25;text-align: center;margin-top: 1%;"><b>Fig. 15. Snippet of survey results. </b>Survey results showing the frequency of CID testing and desired frequency of wearing the CIDosis patch.</figcaption> |
| <br><br> | | <br><br> |
| <b>Ethical Considerations</b><br> | | <b>Ethical Considerations</b><br> |